References
- Kempson R L, Bari W. Uterine sarcomas, classification diagnosis and prognosis. Hum Pathol 1979; 1: 331–49
- Dinh T V, Slavin R E, Bhagavan B S, Hannigan E V, Tiamson E M, Yandell R B. Mixed mesodermal tumors of the ovary: A clinicopathological study of 14 cases. Obstet Gynecol 1988; 72: 409–12
- Morrow C P, Ablaing G, Brady L W, Blessing J A, Hreshchyshyn M M. A clinical and pathologic study of 30 cases of malignant mixed Müllerian epithelial and mesenchymal ovarian tumors. A gynecologic oncology group study. Gynecol Oncol 1984; 18: 278–92
- Lele S B, Piver M S, Barlow J J. Chemotherapy in management of mixed mesodermal tumors of the ovary. Gynecol Oncol 1980; 10: 298–302
- Hanjani P, Petersen R O, Lipton Nolte S. Malignant mixed mesodermal tumors and carcinosarcoma of the ovary: Report of eight cases and review of the literature. Obstet Gynecol Surv 1983; 38: 537–45
- Dictor M. Malignant mixed mesodermal tumor of the ovary: Report of 22 cases. Obstet Gynecol 1985; 65: 720–4
- Anderson B, Turner D A, Benda J. Ovarian sarcoma. Gynecol Oncol 1987; 26: 192–8
- Shakfeh S M, Woodruff J D. Primary ovarian sarcomas: Report of 46 cases and review of the literature. Obstet Gynecol Surv 1987; 42: 331–49
- World Health Organization. WHO handbook for reporting results of cancer treatment. WHO offset publication No. 48, WHO, Genèva 1979
- Kaplan E L, Meier P. Nonparametric estimation from incomplete observations. J Am Statist Assoc 1958; 53: 457–81
- Fleming W P, Peters W A, Kumar N B, Morley G W. Autopsy findings in patients with uterine sarcoma. Gynecol Oncol 1984; 19: 168–72
- Bertelsen K, Jacobsen A, Andersen J E, Ahrons S, Pedersen P H, Kjáer H, Arffmann E, Bichel P, Boestofte E, Christophersen I S, Gregersen E, Hansen M K, Hølund B, Jacobsen M, Jensen H K, Jepsen F L, Larsen G, Nielsen E S, Nyland M, Olsen J, Panduro J, Rank F, Søgaard H. A randomized study of cyclophosphamide and cis‐platinum with or without doxorubucin in advanced ovarian carcinoma. Gynecol Oncol 1987; 28: 161–9
- Suggs C L, III, Lee J L, Choi H, Lewis G C. Malignant mixed mesodermal tumors of the ovary. A report of 13 cases. Am J Clin Oncol 1988; 11: 12–15
- Wheelock J B, Hancock K, Smith K. Cisplatin, doxorubicin and cyclophosphamide (PAC) in the treatment of mixed mesodermal tumor of the ovary. Cancer Treat Rep 1987; 71: 1275–6
- Carlson J A, Edwards C, Wharton J T, Gallagher H S, Delclos L, Rutledge F. Mixed mesodermal sarcoma of the ovary. Treatment with combination radiation therapy and chemotherapy. Cancer 1983; 52: 1473–7
- Hernandez W, DiSaia P J, Morrow C R, Townsend D E. Mixed mesodermal sarcoma of the ovary. Obstet Gynecol 1977; 49: 595–635
- Plaxe S C, Dottino P R, Goodman H M, Deligdisch L, Idelson M, Cohen C J. Clinical features of advanced ovarian mixed mesodermal tumors and treatment with doxorubicin‐ and cis‐platinum‐based chemotherapy. Gynecol Oncol 1990; 37: 244–9
- Grosh W W, Jones H W, III, Burnett L S, Greco F A. Malignant mixed mesodermal tumors of the uterus and ovary treated with cisplatin‐based combination chemotherapy. Gynecol Oncol 1986; 25: 334–9